NPORT-EX 2 NPORT_941382302298519.htm iShares US Medical Devices ETF

Schedule of Investments (unaudited) 

December 31, 2020

   

iShares® U.S. Medical Devices ETF

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

    

Health Care Equipment — 84.1%

    

Abbott Laboratories

     11,045,738     $  1,209,397,854  

ABIOMED Inc.(a)(b)

    318,934       103,398,402  

AngioDynamics Inc.(a)(b)

    268,372       4,114,143  

AtriCure Inc.(a)(b)

    318,145       17,711,132  

Axogen Inc.(a)(b)

    246,575       4,413,692  

Axonics Modulation Technologies Inc.(a)(b)

    206,661       10,316,517  

Baxter International Inc.

     3,605,035       289,268,008  

Becton Dickinson and Co.

     1,658,974       415,108,474  

Boston Scientific Corp.(a)

    10,098,584       363,044,095  

Cantel Medical Corp.

     266,247       20,996,238  

Cardiovascular Systems Inc.(a)(b)

    283,166       12,391,344  

CONMED Corp.

     202,112       22,636,544  

CryoLife Inc.(a)(b)

    274,196       6,473,768  

CryoPort Inc.(a)(b)

    276,459       12,131,021  

Danaher Corp.

     3,233,423       718,272,585  

DexCom Inc.(a)(b)

    677,734       250,571,814  

Edwards Lifesciences Corp.(a)

    4,398,703       401,293,675  

Envista Holdings Corp.(a)(b)

    1,126,713       38,004,029  

GenMark Diagnostics Inc.(a)(b)

    477,304       6,968,638  

Glaukos Corp.(a)(b)

    317,226       23,874,429  

Globus Medical Inc., Class A(a)(b)

    538,062       35,092,404  

Heska Corp.(a)(b)

    62,755       9,140,266  

Hill-Rom Holdings Inc.

     471,772       46,219,503  

Hologic Inc.(a)

    1,814,031       132,115,878  

IDEXX Laboratories Inc.(a)(b)

    602,019       300,931,238  

Inari Medical Inc.(a)(b)

    58,210       5,081,151  

Inogen Inc.(a)(b)

    130,282       5,821,000  

Insulet Corp.(a)(b)

    465,431       118,978,127  

Integer Holdings Corp.(a)(b)

    232,496       18,876,350  

Integra LifeSciences Holdings Corp.(a)(b)

    499,624       32,435,590  

Intersect ENT Inc.(a)

    229,273       5,250,352  

Intuitive Surgical Inc.(a)(b)

    528,414       432,295,493  

iRhythm Technologies Inc.(a)(b)

    203,390       48,246,142  

LeMaitre Vascular Inc.

     120,236       4,869,558  

LivaNova PLC(a)(b)

    342,991       22,709,434  

Masimo Corp.(a)(b)

    357,477       95,939,677  

Medtronic PLC

     8,388,665       982,648,218  

Mesa Laboratories Inc.(b)

    34,271       9,823,439  

Natus Medical Inc.(a)

    240,670       4,823,027  

Nevro Corp.(a)(b)

    242,992       42,061,915  

Novocure Ltd.(a)(b)

    596,298       103,183,406  

NuVasive Inc.(a)(b)

    361,960       20,389,207  

Orthofix Medical Inc.(a)

    136,685       5,874,721  

Penumbra Inc.(a)(b)

    237,854       41,624,450  

ResMed Inc.

     1,022,782       217,402,542  

Shockwave Medical Inc.(a)(b)

    219,589       22,775,771  

STERIS PLC

     602,189       114,138,903  
Security   Shares     Value  

 

  

Health Care Equipment (continued)

    

Stryker Corp.

     1,688,790     $ 413,821,102  

Surmodics Inc.(a)(b)

    96,893       4,216,783  

Tactile Systems Technology Inc.(a)(b)

    136,936       6,153,904  

Tandem Diabetes Care Inc.(a)(b)

    438,898       41,993,761  

Teleflex Inc.(b)

    328,662       135,267,419  

Vapotherm Inc.(a)(b)

    151,587       4,071,627  

Varex Imaging Corp.(a)(b)

    278,382       4,643,412  

Varian Medical Systems Inc.(a)

    644,758       112,839,098  

Zimmer Biomet Holdings Inc.

     1,462,924       225,421,959  
   

 

 

  
      7,757,563,229  
Health Care Services — 0.2%            

BioTelemetry Inc.(a)(b)

    242,869       17,505,997  
   

 

 

  

Health Care Supplies — 0.3%

    

STAAR Surgical Co.(a)

    325,071       25,752,125  
   

 

 

  

Life Sciences Tools & Services — 15.2%

 

  

Bio-Rad Laboratories Inc., Class A(a)

    151,910       88,554,416  

Bruker Corp.

     724,008       39,190,553  

NanoString Technologies Inc.(a)(b)

    310,943       20,795,868  

Thermo Fisher Scientific Inc.

     2,470,026       1,150,488,710  

Waters Corp.(a)

    437,915       108,348,929  
   

 

 

  
      1,407,378,476  
   

 

 

  

Total Common Stocks — 99.8%
(Cost: $7,306,418,215)

 

     9,208,199,827  
   

 

 

  

Short-Term Investments

    

Money Market Funds — 1.8%

    

BlackRock Cash Funds: Institutional, SL Agency Shares, 0.18%(c)(d)(e)

    153,630,039       153,722,217  

BlackRock Cash Funds: Treasury, SL Agency Shares, 0.00%(c)(d)

    10,980,000       10,980,000  
   

 

 

  
      164,702,217  
   

 

 

  

Total Short -Term Investments — 1.8%
(Cost: $164,526,068)

 

     164,702,217  
   

 

 

  

Total Investments in Securities — 101.6%
(Cost: $7,470,944,283)

 

     9,372,902,044  

Other Assets, Less Liabilities — (1.6)%

 

     (147,120,146 ) 
   

 

 

  

Net Assets — 100.0%

 

   $  9,225,781,898  
   

 

 

  

 

(a)

Non-income producing security.

(b)

All or a portion of this security is on loan.

(c) 

Affiliate of the Fund.

(d)

Annualized 7-day yield as of period-end.

(e)

All or a portion of this security was purchased with cash collateral received from loaned securities.

 

 

1

Schedule of Investments (unaudited) (continued)

December 31, 2020

    iShares® U.S. Medical Devices ETF

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the period ended December 31, 2020 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

       Affiliated Issuer  

Value at

03/31/20

    

Purchases

at Cost

    

Proceeds

from Sales

    

Net Realized

Gain (Loss)

    

Change in

Unrealized

Appreciation

(Depreciation)

    

Value at

12/31/20

    

Shares

Held at

12/31/20

     Income    

Capital

Gain

Distributions

from

Underlying

Funds

    

    

  
 

BlackRock Cash Funds: Institutional, SL Agency Shares

   $ 168,274,046     $ —     $ (14,771,263 )(a)    $ 138,252     $ 81,182     $ 153,722,217       153,630,039     $ 715,642 (b)    $ —    
 

BlackRock Cash Funds: Treasury, SL Agency Shares

     9,823,000       1,157,000 (a)      —       —       —       10,980,000       10,980,000       12,440       —    
         

 

 

    

 

 

    

 

 

      

 

 

    

 

 

    
          $ 138,252     $ 81,182     $ 164,702,217       $ 728,082     $ —    
         

 

 

    

 

 

    

 

 

      

 

 

    

 

 

    

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

Futures Contracts

 

Description   

Number of

Contracts

     

Expiration

Date

     

Notional

Amount

(000)

     

Value/

Unrealized

Appreciation

(Depreciation)

  

Long Contracts

            

S&P Select Sector Health Care E-Mini Index

      110        03/19/21      $ 12,607      $ 243,589  

S&P Select Sector Technology E-Mini Index

      22        03/19/21        2,884        122,830  
           

 

 

  
            $ 366,419  
           

 

 

  

Fair Value Measurements

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to a recently published shareholder report. Shareholder reports are available on the Fund’s website at iShares.com and on the U.S. Securities and Exchange Commission website at sec.gov.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of December 31, 2020. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.

 

                                                                                                   
      Level 1      Level 2      Level 3      Total  

Investments

            

Assets

            

Common Stocks

    $ 9,208,199,827      $ —      $ —      $ 9,208,199,827  

Money Market Funds

      164,702,217        —        —        164,702,217  
  

 

 

     

 

 

     

 

 

     

 

 

  
   $ 9,372,902,044      $ —      $ —      $ 9,372,902,044  
  

 

 

     

 

 

     

 

 

     

 

 

  

Derivative financial instruments(a)

           

Assets

            

Futures Contracts

    $ 366,419      $ —      $ —      $ 366,419  
  

 

 

     

 

 

     

 

 

     

 

 

  

 

  (a)

Shown at the unrealized appreciation (depreciation) on the contracts.    

 

 

2